ApprovalTrail

Approval · Notice of Compliance 36334 · 2025

SIMPONI: Notice of Compliance 36334

Issued November 5, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
36334
Date
November 5, 2025
Company
Janssen Inc.Toronto, Ontario, Canada
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Label updates

Products in this notice

BrandDINStatus today
SIMPONINot yet assigned—

Medicinal ingredients